×

Oncolytic vaccinia virus cancer therapy

  • US 9,919,062 B2
  • Filed: 12/11/2015
  • Issued: 03/20/2018
  • Est. Priority Date: 09/07/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of inducing oncolysis in a human subject having a tumor comprising intratumorally administering to said subject one or more single doses of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a purified TK-deficient, replication-competent vaccinia virus vector wherein said single dose comprises at least 1×

  • 109 pfu.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×